Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Sep 1;6(1):96–112. doi: 10.36469/9791

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CCBY-4.0). View this license’s legal deed at http://creativecommons.org/licenses/by/4.0 and legal code at http://creativecommons.org/licenses/by/4.0/legalcode for more information.

PMC Copyright notice

Proportion of Patients with UC and CD Who Received the Same Biologic Throughout Follow-up

Proportion of patients with UC (A and B) or CD (C and D) who continued to receive the same biologic initiated throughout the follow-up period: 1 year (primary analyses; A and C) and 2 years (secondary analyses; B and D) (1- and 2-year follow-up cohorts). N numbers represent the number of patients who started a given biologic (ITT population), while the percentage shows the proportion of patients who continued receiving the same biologic over the follow-up period (as-treated population).

CD: Crohn’s disease; ITT: intention-to-treat; UC: ulcerative colitis